MARKET

AYTU

AYTU

Aytu Biopharma Inc
NASDAQ
2.090
-0.110
-5.00%
Opening 14:14 06/16 EDT
OPEN
2.200
PREV CLOSE
2.200
HIGH
2.200
LOW
2.090
VOLUME
75.35K
TURNOVER
--
52 WEEK HIGH
3.065
52 WEEK LOW
1.650
MARKET CAP
22.43M
P/E (TTM)
-0.4740
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at AYTU last week (0608-0612)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 4d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 5d ago
Aytu BioPharma Is Maintained at Buy by Ascendiant Capital
Dow Jones · 5d ago
Aytu BioPharma Price Target Raised to $14.50/Share From $14.00 by Ascendiant Capital
Dow Jones · 5d ago
Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $14.5
Benzinga · 5d ago
Weekly Report: what happened at AYTU last week (0601-0605)?
Weekly Report · 06/08 09:30
Aytu BioPharma to present at Planet MicroCap Las Vegas 2026 investor conference fireside Q&A
PUBT · 06/01 20:15
More
About AYTU
Aytu BioPharma, Inc. is a pharmaceutical company focused on advancing medicines for complex central nervous system (CNS) diseases. Its business is focused on the launch of EXXUA and its prescription pharmaceutical products sold primarily through third-party wholesalers and pharmacies and which primarily consists of two product portfolios. Its Attention Deficit Hyperactivity Disorder (ADHD) portfolio consists of Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) , Cotempla XR-ODT, and METADATE CD, which are CNS stimulants indicated for the treatment of ADHD in patients. Its Pediatric portfolio consists of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine indicated to treat various allergic conditions including seasonal and perennial allergic rhinitis, vasomotor rhinitis, Poly-Vi-Flor, and Tri-Vi-Flor. EXXUA is indicated to treat depressive disorder (MDD) in adults.

Webull offers Aytu Biopharma Inc stock information, including NASDAQ: AYTU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AYTU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AYTU stock methods without spending real money on the virtual paper trading platform.